Showing 1 — 20 of 76
SORT: Best Match Most Recent Oldest
VIEW: Basic | Expanded
  • Original Contribution April 10, 2013

    Mingzhao Xing, MD, PhD; Ali S. Alzahrani, MD; Kathryn A. Carson, ScM; David Viola, MD; Rossella Elisei, MD; Bela Bendlova, PhD; Linwah Yip, MD; Caterina Mian, MD; Federica Vianello, MD; R. Michael Tuttle, MD; Eyal Robenshtok, MD; James A. Fagin, MD; Efisio Puxeddu, MD, PhD; Laura Fugazzola, MD; Agnieszka Czarniecka, MD; Barbara Jarzab, MD, PhD; Christine J. O’Neill, MBBS(Hons), MS; Mark S. Sywak, MD; Alfred K. Lam, MD, PhD; Garcilaso Riesco-Eizaguirre, MD, PhD; Pilar Santisteban, PhD; Hirotaka Nakayama, MD; Ralph P. Tufano, MD; Sara I. Pai, M.D, PhD; Martha A. Zeiger, MD; William H. Westra, MD; Douglas P. Clark, MD; Roderick Clifton-Bligh, PhD; David Sidransky, MD; Paul W. Ladenson, MD; Vlasta Sykorova, PhD
    TOPICS: mortality, neoplasms, thyroid carcinoma, papillary, metastasis, distant, braf gene, braf v600e mutation

    JAMA. 2013; 309(14):1493-1501. doi: 10.1001/jama.2013.3190

    Includes: Supplemental Content
  • ARTICLE January 17, 1972

    Athanasios Theologides, MD; Ju-Chin Lee, MD

    JAMA. 1972; 219(3):384-384. doi: 10.1001/jama.1972.03190290070023